X-Received: by 2002:ad4:4ee3:0:b0:472:f785:593e with SMTP id dv3-20020ad44ee3000000b00472f785593emr6103945qvb.51.1658631056469;
Sat, 23 Jul 2022 19:50:56 -0700 (PDT)
X-Received: by 2002:a0c:c789:0:b0:470:8c5b:5e13 with SMTP id
k9-20020a0cc789000000b004708c5b5e13mr6015277qvj.86.1658631056277; Sat, 23 Jul
2022 19:50:56 -0700 (PDT)
Path: i2pn2.org!i2pn.org!usenet.blueworldhosting.com!feed1.usenet.blueworldhosting.com!peer01.iad!feed-me.highwinds-media.com!news.highwinds-media.com!news-out.google.com!nntp.google.com!postnews.google.com!google-groups.googlegroups.com!not-for-mail
Newsgroups: sci.space.policy
Date: Sat, 23 Jul 2022 19:50:56 -0700 (PDT)
Injection-Info: google-groups.googlegroups.com; posting-host=146.70.99.170; posting-account=kguFRwoAAABSYr28ARGY1F28SAxxolRF
NNTP-Posting-Host: 146.70.99.170
User-Agent: G2/1.0
MIME-Version: 1.0
Message-ID: <f465046c-5dcf-435c-8ddf-cd7b69dca93bn@googlegroups.com>
Subject: (PDF) Gene Therapy for Viral Infections by Patrick Arbuthnot
From: hesterho...@gmail.com (hester holt)
Injection-Date: Sun, 24 Jul 2022 02:50:56 +0000
Content-Type: text/plain; charset="UTF-8"
X-Received-Bytes: 1219